N-of-1 trial of low-dose methotrexate and/or prednisolone in lieu of anti-CCP, MRI, or ultrasound, as first option in suspected rheumatoid arthritis?
Pincus
Theodore
T
Huizinga
Tom W J
TW
Yazici
Yusuf
Y
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000906:Antibodies / Q000097:blood; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D042241:Early Diagnosis; D006801:Humans; D007596:Joints / Q000000981:diagnostic imaging / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008727:Methotrexate / Q000627:therapeutic use*; D010456:Peptides, Cyclic / Q000276:immunology; D011239:Prednisolone / Q000627:therapeutic use*; D014463:Ultrasonography
D000893:Anti-Inflammatory Agents; D000906:Antibodies; D018501:Antirheumatic Agents; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide; D011239:Prednisolone; D008727:Methotrexate